Circulating uncarboxylated matrix Gla protein in patients with atrial fibrillation or heart failure with preserved ejection fraction

Arch Physiol Biochem. 2022 Dec;128(6):1619-1629. doi: 10.1080/13813455.2020.1786130. Epub 2020 Jul 3.

Abstract

Context: Circulating uncarboxylated matrix Gla protein (ucMGP) is possibly related to coronary arterial calcification (CAC) in cardiovascular disease (CVD) patients.

Objective: We aimed to evaluate the relationships between circulating ucMGP, CVD pathology and CAC and its interplay with CVD risk factors.

Materials and methods: ucMGP was measured in 99 CVD-patients. CAC score was determined by multislice computed tomography. Circulating ucMGP, uncarboxylated (ucOC) and carboxylated osteocalcin (cOC) were assayed by ELISA kits. Vitamin-K status was evaluated by ucOC/cOC ratio.

Results: A tendency for decreased ucMGP was observed for CAC 100 AU vs. CAC = 1-99 AU after exclusion of the patients on vitamin K-antagonist anticoagulants. Significant inverse correlations between ucMGP and vitamin-K status were indicated for the entire cohort and according to CAC score. Significant associations were found between ucMGP and risk factors for CVD.

Conclusion: Circulating ucMGP may reflect certain stages of CVD and CAC. Future studies are needed to clarify its role as potential biomarker.

Keywords: artery calcification; cardiovascular diseases; matrix Gla protein.

MeSH terms

  • Anticoagulants
  • Atrial Fibrillation*
  • Biomarkers
  • Calcinosis*
  • Calcium-Binding Proteins
  • Extracellular Matrix Proteins
  • Heart Failure*
  • Humans
  • Matrix Gla Protein
  • Osteocalcin
  • Stroke Volume
  • Vitamin K
  • Vitamins

Substances

  • Osteocalcin
  • Extracellular Matrix Proteins
  • Calcium-Binding Proteins
  • Vitamin K
  • Biomarkers
  • Vitamins
  • Anticoagulants